Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Su Jeen Lee
Observed name:
Su Jin Lee
Institution:
Korea Research Institute of Chemical Technology
Observed institutions:
Korea Research Institute of Chemical Technology,
SK bioscience Co., Ltd. (South Korea),
Hanyang University,
Catholic University of Korea
ORCID:
0000-0003-3370-0735
Observed ORCID:
0000-0003-3370-0735
OpenAlex ID:
A5017451019
Safety and immunogenicity of a SARS-CoV-2 recombinant protein nanoparticle vaccine (GBP510) adjuvanted with AS03: A randomised, placebo-controlled, observer-blinded phase 1/2 trial
2022
·
Joon Young Song
, Won Suk Choi
, et al.
·
EClinicalMedicine
·
97
PDF
Immunogenicity and safety of SARS-CoV-2 recombinant protein nanoparticle vaccine GBP510 adjuvanted with AS03: interim results of a randomised, active-controlled, observer-blinded, phase 3 trial
2023
·
Joon Young Song
, Won Suk Choi
, et al.
·
EClinicalMedicine
·
55
PDF
Immunization with RBD-P2 and N protects against SARS-CoV-2 in nonhuman primates
2021
·
So-Hee Hong
, Hanseul Oh
, et al.
·
Science Advances
·
38
Immunogenicity and protective efficacy of GBP510/AS03 vaccine against SARS-CoV-2 delta challenge in rhesus macaques
2023
·
Catherine Jacob-Dolan
, Jingyou Yu
, et al.
·
npj Vaccines
·
25
PDF
Immunogenicity and Safety of a Newly Developed Live Attenuated Varicella Vaccine in Healthy Children: A Multi-National, Randomized, Double-Blinded, Active-Controlled, Phase 3 Study
2023
·
Ui Yoon Choi
, Ki Hwan Kim
, et al.
·
Vaccines
·
14
PDF
Evaluation of glycoprotein E subunit and live attenuated varicella‐zoster virus vaccines formulated with a single‐strand RNA‐based adjuvant
2020
·
Su Jeen Lee
, Hyo‐Jung Park
, et al.
·
Immunity Inflammation and Disease
·
13
PDF
Induction of granulocytic differentiation in acute promyelocytic leukemia cells (HL-60) by 2-(allylthio) pyrazine
1999
·
Gu Kong
, Su Jeen Lee
, et al.
·
Cancer Letters
·
12
Immune evasion and pathogenesis of henipaviruses
2026
·
Juwan Kim
, Su Jin Lee
, et al.
·
Current Opinion in Virology
·
9
Recombinant measles virus encoding the spike protein of SARS-CoV-2 efficiently induces Th1 responses and neutralizing antibodies that block SARS-CoV-2 variants
2023
·
Hye Won Kwak
, Hyo-Jung Park
, et al.
·
Vaccine
·
7
PDF
Immune Responses to Varicella Zoster Virus and Effective Vaccines
2021
·
Su Jeen Lee
, Hun Kim
, et al.
·
Journal of Bacteriology and Virology
·
7
PDF
Intranasal immunization with the recombinant measles virus encoding the spike protein of SARS-CoV-2 confers protective immunity against COVID-19 in hamsters
2023
·
Sang-In Park
, Sohyun Park
, et al.
·
Vaccine
·
6
Large-Scale Production of Rotavirus VLP as Vaccine Candidate Using Baculovirus Expression Vector System (BEVS)
2004
·
Jin Yong Park
, Hun Kim
, et al.
·
Journal of Microbiology and Biotechnology
·
6
A booster administration of the OKA/SK strain causes fatal disseminated varicella in an immunocompetent child
2024
·
Seong‐Beom Park
, Su Jeen Lee
, et al.
·
Journal of Medical Virology
·
3
PDF
Safety and immunogenicity of a homologous booster dose of a SARS-CoV-2 recombinant protein nanoparticle vaccine (GBP510) adjuvanted with AS03: 12 months follow-up result of an open-label, nonrandomized extension of a phase 1/2 trial
2025
·
Joon Young Song
, Won Suk Choi
, et al.
·
International Journal of Infectious Diseases
·
1
Letter to the Editor: A booster administration of the OKA/SK strain causes fatal disseminated varicella in an immunocompetent child
2024
·
Seong-Beom Park
, Su Jeen Lee
, et al.
PDF
Corrigendum to “Recombinant measles virus encoding the spike protein of SARS-CoV-2 efficiently induces Th1 responses and neutralizing antibodies that block SARS-CoV-2 variants” [Vaccine 41(11) (2023) 1892–1901]
2023
·
Hye Won Kwak
, Hyo-Jung Park
, et al.
·
Vaccine
Show more works
View as search
Works count:
16
Citation count:
293
H-index:
8
I10-index:
7
Year
Topic
Type